理邦仪器 reported revenue of ¥1.02B for the period ended 2026-06-30, +12.0% year on year. Net income was ¥0.20B, a 20.0% net margin on a 59.6% gross margin. The largest revenue line is 病人监护 at 31% of the total. Free cash flow for the period was ¥0.13B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥1.02B | +12.0% |
| Gross profit | ¥0.61B | — |
| Operating income | ¥0.22B | — |
| Net income | ¥0.20B | +32.0% |
| Gross margin | 59.6% | Net margin 20.0% |
| Revenue Q/Q | -1.8% | — |
| Segment | Revenue | Share |
|---|---|---|
| 病人监护 | ¥0.31B | 30.7% |
| 体外诊断 | ¥0.23B | 22.2% |
| 超声影像 | ¥0.18B | 17.7% |
| 心电诊断 | ¥0.15B | 14.6% |
| 妇幼健康 | ¥0.13B | 13.1% |
| 其他(补充) | ¥0.01B | 1.4% |
| 检测服务及其他 | ¥0.00B | 0.4% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.41B | 40.4% |
| R&D | ¥0.13B | 13.1% |
| SG&A | ¥0.25B | 24.1% |
| Tax & other | ¥0.02B | 1.7% |
| Item | Amount |
|---|---|
| Total assets | ¥2.60B |
| Total liabilities | ¥0.38B |
| Shareholders' equity | ¥2.22B |
| Equity / assets | 85.3% |
| Operating cash flow | ¥0.14B |
| Capital expenditure | ¥0.01B |
| Free cash flow | ¥0.13B |
| Cash conversion (OCF / net income) | 75% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
欣旺达 ・ 行云科技 ・ 森远股份 ・ *ST亿通 ・ *ST易录 ・ 佳讯飞鸿 ・ 日科化学 ・ 电科院 ・ 东方电热 ・ 安利股份 ・ 鸿利智汇 ・ 金运激光
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies